KATELYN SCAGNELLI
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care LOWELL, MA NPI 1760634943
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care MA Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,002.57
- Category: General Payments
- Program years: PY2021–2024
- Record count: 19
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $502.98 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $280.00 | 1 |
| Food and Beverage | $222.98 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $280.00 | 1 |
| GlaxoSmithKline, LLC. | $97.66 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.98 | 1 |
| PFIZER INC. | $29.20 | 1 |
| Genentech USA, Inc. | $27.84 | 1 |
| Celgene Corporation | $21.56 | 1 |
| Novocure Inc. | $14.74 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1101127110 | Celgene Corporation | $21.56 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104561304 | AstraZeneca Pharmaceuticals LP | $280.00 | 08/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1116585243 | GlaxoSmithKline, LLC. | $97.66 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1123336656 | Novocure Inc. | $14.74 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131296949 | PFIZER INC. | $29.20 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133166660 | Genentech USA, Inc. | $27.84 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144983220 | Takeda Pharmaceuticals U.S.A., Inc. | $31.98 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.